To investigate injection drug use–associated endogenous endophthalmitis (IDU-EE) and identify critical opportunities for early intervention in patients with substance use disorders (SUD) to improve health outcomes.
Key Findings:
Fentanyl use was associated with worse visual outcomes compared to other drugs.
Patients presenting with acute vision loss, floaters, eye pain, or photophobia should be evaluated for IDU-EE.
No opioid use disorder medication was administered without addiction consult services involvement, highlighting a critical gap in care.
Interpretation:
The study highlights the critical role of ophthalmologists in identifying and treating IDU-EE while also addressing underlying substance use disorders through coordinated care, which is essential for improving public health outcomes.
Limitations:
Limited access to ophthalmic equipment in some emergency departments may hinder diagnosis.
The study's findings may not be generalizable beyond the specific healthcare system analyzed, and potential biases in data collection should be considered.
Conclusion:
Ophthalmologists have a unique opportunity to connect patients with substance use disorders to addiction treatment during hospitalization for IDU-EE, potentially improving both vision and overall health outcomes through interdisciplinary collaboration.
